Archives

by in
Entry Author Date Location
Gates Bets on Computer Drug Discovery, Tachi Yamada Joins Frazier, Dendreon’s LA OK, & More in Seattle-Area Life Sciences News 06/30/11 Seattle
Tachi Yamada, Former Gates Foundation Leader, Joins Frazier for New VC Gig 06/27/11 Seattle
Calibra Medical, Maker of Cheap Mechanical Insulin Pump, Pockets $8.1 M 04/14/11 San Francisco
Dendreon Wins Medicare Coverage, Clarisonic Tops $100M in Sales, Sage Partners Up, & More Seattle-Area Life Sciences News 03/31/11 Seattle
Frazier Buys Carefusion Unit 03/29/11 San Diego
Calypso Medical’s New CEO Seeks to Steady Ship After a Rough Couple of Years 03/09/11 Seattle
Gilead Buys Calistoga Pharma for $375M, Making Move Into Cancer Drugs 02/22/11 Seattle
Tachi Yamada, Gates Foundation’s Global Health Leader, Stepping Down in June 02/14/11 Seattle
Stromedix Chief, After Reloading the Company Treasury, Sets Sight on Trial for Deadly Lung Disease 02/07/11 Boston
See You Tonight at “San Diego’s Fight Against Diabesity” 01/27/11 San Diego
$2M Debt Funding for Stromedix 01/26/11 Boston
Calibra, Inspired by Inventor With Diabetes, Homes in on Cheap, Easy Way to Deliver Insulin 01/24/11 San Francisco
J&J Subsidiary Backs Alzheimer Drug Discovery at Sanford-Burnham, Portable Genomics to Move to San Diego, Ardea Plans Secondary Stock Offering, & More San Diego Life Sciences News 01/20/11 San Diego
Patients’ Parents Upset By FDA Panel’s Rejection of Lilly/Alnara’s Cystic Fibrosis Drug 01/19/11 Boston
How Can San Diego Win the Fight Against Diabesity? Xconomy to Dig Deep on Jan. 27 12/27/10 San Diego
San Diego’s Fight Against Diabesity: Can Investors Make Money, and Can Startups Still Thrive? 12/03/10 San Diego
The Fight Against Diabesity: How Will San Diego Adapt in the Era of Tough FDA Scrutiny? 11/22/10 San Diego
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move 11/08/10 Seattle
VentiRx, With Venti-Sized Ambition to Treat (and Maybe Prevent) Allergies, Passes First Big Test 10/07/10 Seattle
Affymax Isn’t Dead Yet, ZeaChem Pursues Wood Chip Ethanol, Third Rock Heads West, & More Bay Area Life Sciences News 08/13/10 San Francisco
Trubion Pharmaceuticals Gets Acquired by Emergent BioSolutions for $97M Upfront 08/12/10 Seattle
Nuon Adds $10M Debt, Options 08/12/10 San Francisco
CEO Eric Meier Out at Calypso Medical; Layoffs Reported 08/06/10 Seattle
Eli Lilly Pays up to $380M for Alnara Pharma 07/20/10 Boston
Achaogen, Flush with $56M, Seeks to Build Lasting Company with Potent Antibiotics 07/19/10 San Francisco
BARRX Medical Secures $15,000,000 Series D Financing 07/14/10 San Francisco
Google Pays $700M for ITA, Eli Lilly Buys Alnara, Skyhook Lands Samsung Partnership, & More Boston-Area Deals News 07/07/10 Boston
Calistoga Pharmaceuticals Nabs $40M in Washington’s Biggest Venture Deal of 2010 06/30/10 Seattle
Calistoga Pharmaceuticals Garners $40,000,000 Series C Funding 06/30/10 Seattle
Three Medical Device Deals to Wrap Up: Voyage Medical, Incline Therapeutics, and Baxano 06/22/10 San Francisco
Page 2 of 5 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Zillions of Biotech Conferences Want You. Which Should You Attend?

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.